Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
about
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesIs lipid signaling through cannabinoid 2 receptors part of a protective system?Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in miceLipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assayCB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseaseAlternative targets within the endocannabinoid system for future treatment of gastrointestinal diseasesUlcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissueThe Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of ObesityInhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in miceCannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated ratsRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationModulation of gut-specific mechanisms by chronic δ(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis.Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat DietStructural basis of G protein-coupled receptor-Gi protein interaction: formation of the cannabinoid CB2 receptor-Gi protein complexCB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Cannabinoid hyperemesis syndrome.The role of cannabinoids in regulation of nausea and vomiting, and visceral pain.Environment-related adaptive changes of gut commensal microbiota do not alter colonic toll-like receptors but modulate the local expression of sensory-related systems in rats.Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute simian immunodeficiency virus infection of rhesus macaquesAntibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.Ethnopharmacological Survey of Plants Used in the Traditional Treatment of Gastrointestinal Pain, Inflammation and Diarrhea in Africa: Future Perspectives for Integration into Modern Medicine.β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice.Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases.A potential role for GPR55 in gastrointestinal functionsModulating the endocannabinoid system in human health and disease--successes and failuresMetabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.Cannabinoid receptor CB2 protects against balloon-induced neointima formation.Molecular development of the extrinsic sensory innervation of the gastrointestinal tract.Emerging strategies for exploiting cannabinoid receptor agonists as medicines.Role of cannabinoid receptors in the control of gastrointestinal motility and perception.The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding.The emerging role of the endocannabinoid system in cardiovascular disease.Therapeutic Use of Cannabis in Inflammatory Bowel Disease.Signal transduction via cannabinoid receptors.
P2860
Q24623282-2EFB6AF6-B613-4FE4-AA65-82CAE2336712Q24633122-8ADFAE6A-F21A-4589-8B89-9F711E605D20Q24645241-F2C272C1-B447-4E68-865F-DA3476591CA1Q24654730-C485AC29-1F28-46C6-ABC2-3769A9C0E85EQ26746050-DF189DC0-685A-4E02-96E3-B4BC899F04B4Q26824588-ABAF0798-17C9-484E-9153-BBFEA86FD40EQ27342536-7C0798A4-FA67-4618-9536-0E7ED26A42B9Q28067835-BFF45477-D84A-4701-AFF2-37A898958A75Q28258759-60EF27A1-5619-4226-B14F-EDEAD3D2AD19Q28568772-18C121E2-135F-4321-88D7-E0577C8FA735Q30357558-0396841F-E289-4E9D-BB6A-125F8052A464Q33713868-DE2754E1-00E5-4BFA-8D36-FDEA38517ADDQ33721328-915E570F-3AC2-4A50-8095-87D0940FB879Q33931230-B6C16B3C-61EC-4763-9595-B4BBC493B0A4Q34186015-D4D2BAC2-AAC0-4F37-A4F8-BB2A1F50B553Q34239091-7EF0A202-08D0-4929-82AC-ACEB0194782BQ34464535-3145C37A-D7FA-4185-97AA-48E3DEE91C1EQ34716086-E5EED4B4-FA24-49E8-A008-C08544443DD6Q34991150-DE0763B3-9179-4750-A9BF-13397601DE14Q35532177-D71EFF18-1B7D-4CB4-B662-C58E06A384E5Q35830360-547299C9-CB87-4136-B75A-8FC71B07AFCAQ35854652-7C386320-72E4-46DF-A220-D5A4797A1502Q35927832-589543BB-039E-4C83-9EBD-96E42DA41821Q36024979-01D8551C-2B13-4458-81D2-A18B0D0D1ACEQ36089227-1483DF34-03AE-4F7A-A33F-092C8C7723B3Q36496316-0CE56831-95F2-488A-B52B-9409D593B5E0Q36864469-27FDE834-1EDA-409C-8127-C97C05550758Q36933683-D40FCA67-DDD0-4CB0-A2A7-B01364AF4B0EQ36947747-03AE2143-7D6B-4D53-94AC-C098D135C029Q36977483-244D03CB-4707-4F73-A31B-ABBDE9F81C81Q37032490-AA887106-EF4D-4D26-9AD7-780DCEE10A18Q37174735-F912FAEB-527F-433E-ACD6-C97A57128C69Q37215690-1F112906-C998-4B53-B84C-A44698976B61Q37230665-031386CA-1B62-4B0A-9416-38C16A4AED8CQ37345943-2560780D-A91A-415D-BFE7-6A9C6A7A67EDQ37375986-96E60350-10F5-4314-A66C-FB19E4200574Q37376946-F36544C5-8855-4DB1-AE8C-CD3CB64F7A7FQ37439386-AAA2B047-4902-417A-856F-DAEC46615C7AQ37540208-B6DC607F-7A9C-4D68-8D5C-E16BF2F8F353Q37617453-CA46732D-6058-4035-9EF8-D44BD9166361
P2860
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cannabinoid CB2 receptors in t ...... stem in states of inflammation
@ast
Cannabinoid CB2 receptors in t ...... stem in states of inflammation
@en
Cannabinoid CB2 receptors in t ...... stem in states of inflammation
@nl
type
label
Cannabinoid CB2 receptors in t ...... stem in states of inflammation
@ast
Cannabinoid CB2 receptors in t ...... stem in states of inflammation
@en
Cannabinoid CB2 receptors in t ...... stem in states of inflammation
@nl
prefLabel
Cannabinoid CB2 receptors in t ...... stem in states of inflammation
@ast
Cannabinoid CB2 receptors in t ...... stem in states of inflammation
@en
Cannabinoid CB2 receptors in t ...... stem in states of inflammation
@nl
P2860
P921
P3181
P356
P1476
Cannabinoid CB2 receptors in t ...... stem in states of inflammation
@en
P2093
P2860
P304
P3181
P356
10.1038/SJ.BJP.0707486
P407
P577
2007-10-01T00:00:00Z